e-learning
resources
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
“Why do some adults with PiMZ apha1-antitrypsin develop bronchiectasis?”
Nupur Aggarwal, Beatriz Martinez Delgado, Sandeep Salipalli, Nerea Matamala, Jessica Rademacher, Nicolaus Schwerk, Tobias Welte, Sabina Janciauskiene and Felix C. Ringshausen
Source:
ERJ Open Res 2016: 50021-2016-ERR
Journal Issue:
July
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nupur Aggarwal, Beatriz Martinez Delgado, Sandeep Salipalli, Nerea Matamala, Jessica Rademacher, Nicolaus Schwerk, Tobias Welte, Sabina Janciauskiene and Felix C. Ringshausen. “Why do some adults with PiMZ apha1-antitrypsin develop bronchiectasis?”. ERJ Open Res 2016: 50021-2016-ERR
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
ERS clinical practice guidelines on bronchiectasis in children
Related content which might interest you:
Why do some adults with PiMZ a1-antitrypin develop bronchiectasis?
Source: ERJ Open Res 2016: 00021-2016
Year: 2016
What does healthy people know about asthma?
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011
Self-management support for asthma and airways disease – what do patients want?
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 2
Year: 2020
Why do adolescents grow out of their asthma?
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010
What do patients with COPD need to know?
Source: Eur Respir J 2003; 22: Suppl. 45, 168s
Year: 2003
What’s new in interstitial lung diseases in children?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021
Is bronchiectasis really a disease?
Source: Eur Respir Rev, 29 (155) 190051; 10.1183/16000617.0051-2019
Year: 2020
What is COPD? What is asthma?
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
How many young adults are at risk of COPD?
Source: Eur Respir J 2002; 20: Suppl. 38, 124s
Year: 2002
How children with asthma breathe: have we been overlooking a problem?
Source: Eur Respir J 2013; 41: 1008-1009
Year: 2013
Is there an association between tracheomalacia and bronchiectasis in children?
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021
Undiagnosed coeliac disease in patients with emphysema: a fortuitous association?
Source: Eur Respir J 2010; 36: 453
Year: 2010
What do patients want? Preferences for two asthma regimens in mild/moderate asthma
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Only severe asthma?
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019
Chronic diseases like asthma and COPD: do they truly exist?
Source: Eur Respir J 2016; 47: 359-361
Year: 2016
Aspergillus
-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?
Source: Eur Respir Rev, 30 (162) 210103; 10.1183/16000617.0103-2021
Year: 2021
How are we going to treat IPF patients in the future?
Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept